Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 463
Immune Disorders Drugs 194
Cardiovascular Drugs 153
Biopharmaceuticals 132
Infectious Diseases Drugs 121
Drug Discovery 104
Central Nervous System Drugs 104
Endocrine and Metabolic Disorders Drugs 102
Musculoskeletal Disorders Drugs 93
Pharmaceuticals 90
Clinical Trials 90
Leukemia Drugs 82
Hematological Drugs 81
Liver and Kidney Disorders Drugs 74
Lymphoma Drugs 64
Dermatological Drugs 60
Diabetes Drugs 53
Skin Cancer Drugs 50
Brain Cancer Drugs 47
Mental Disorders Drugs 41
Lung Cancer Drugs 40
Respiratory Drugs 38
Immunosuppressive Drugs 36
Gastrointestinal Drugs 34
Drug Delivery 32
Pharmaceutical Intermediates 30
Liver Cancer Drugs 30
Infusions and Injectables 30
Pharmaceutical Manufacturing 27
Analgesics 26
Bladder Cancer Drugs 25
Drugs by Therapeutic Area 23
Kidney Cancer Drugs 22
Antibiotics 22
HIV/AIDS Drugs 22
Breast Cancer Drugs 18
Ovarian Cancer Drugs 17
Colon Cancer Drugs 17
Cervical Cancer Drugs 17
Pancreatic Cancer Drugs 17
Psoriasis Drugs 17
Prostate Cancer Drugs 16
Urological Disorders Drugs 16
Schizophrenia Drugs 15
Thyroid Cancer Drugs 14
Sexual and Reproductive Health Drugs 14
Cancer Vaccines 13
Over the Counter (OTC) Drugs 12
Biosimilars and Biosuperiors 10
Optical Disorders Drugs 8
Generic Drugs 8
Alzheimer's Disease Drugs 8
Transdermal and Transmucosal Drug Delivery 7
Vaccines 7
Uterine Cancer Drugs 7
Cough and Cold Drugs 6
Anti-Obesity Drugs 6
Anxiety Drugs 6
Company Reports 5
Pharmacoeconomics 3
Vitamins and Dietary Supplements 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Asthma Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Allergy Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



282 reviews

2,373 Results (Page 12 of 119)
- Relevance
  Sort by

Immunosuppressants - Global Strategic Business Report

 Report
June 2026
349 Pages
Global

From

€5314EUR$5,850USD£4,588GBP

Schizophrenia Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4079EUR$4,490USD£3,521GBP

Glioma - Competitive Landscape, 2026

 Report
January 2026
450 Pages
Global

From

€4542EUR$5,000USD£3,921GBP

HIV Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

 Report
February 2024
99 Pages
Global

From

€3500EUR$4,127USD£3,127GBP

Option and Evaluation Deals in Pharmaceuticals and Biotechnology 2019-2026

 Report
March 2026
600 Pages
Global

From

€3629EUR$3,995USD£3,133GBP

NEED HELP FINDING THE RIGHT PRODUCT? Hoseok will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Joint Venture Deals in Pharmaceuticals and Biotechnology 2016-2026

 Report
March 2026
250 Days
Global

From

€3629EUR$3,995USD£3,133GBP

Immune Checkpoint Inhibitors for Lung Cancer Market - Global Forecast 2026-2032

 Report
January 2026
182 Pages
Global

From

€3220EUR$3,545USD£2,780GBP

€3578EUR$3,939USD£3,089GBP

Lung Cancer Therapeutics Market by Therapy Type, Mode of Administration, Line of Therapy, Disease Stage, Prescription Status, Distribution Channel, Cancer Type, End User - Global Forecast 2026-2032

 Report
June 2026
193 Pages
Global

From

€3220EUR$3,545USD£2,780GBP

€3578EUR$3,939USD£3,089GBP

Non-small Cell Lung Cancer Therapeutics Market by Treatment Type, Line of Therapy, Biomarker Expression, End User, Distribution Channel - Global Forecast 2026-2032

 Report
June 2026
187 Pages
Global

From

€3220EUR$3,545USD£2,780GBP

€3578EUR$3,939USD£3,089GBP

Extensive Stage Small Cell Lung Cancer Market - Global Forecast 2026-2032

 Report
January 2026
195 Pages
Global

From

€3220EUR$3,545USD£2,780GBP

€3578EUR$3,939USD£3,089GBP

Schizophrenia Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

 Report
January 2026
180 Pages
Global

From

€4088EUR$4,500USD£3,529GBP

Lung Cancer Drugs Market by Therapeutic Class, Cancer Type, Molecule Type, Route of Administration, Product Category, End User, Distribution Channel - Global Forecast 2026-2032

 Report
June 2026
185 Pages
Global

From

€3220EUR$3,545USD£2,780GBP

€3578EUR$3,939USD£3,089GBP

Tuberculosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
September 2022
359 Pages
Global

From

€2271EUR$2,500USD£1,961GBP

Colorectal Cancer Therapeutics Market Size, Share & Trends Analysis Report By Drug Class (Chemotherapy, Immunotherapy), By Region (North America, Asia Pacific, Latin America, Europe), And Segment Forecasts, 2023 - 2030

 Report
September 2023
100 Pages
Global

From

€5405EUR$5,950USD£4,666GBP

Febrile Neutropenia - Pipeline Insight, 2025

 Clinical Trials
April 2025
65 Pages
Global

From

€1363EUR$1,500USD£1,176GBP

Kidney Cancer (Renal Cell Cancer) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
December 2022
322 Pages
Global

From

€2271EUR$2,500USD£1,961GBP

Lung Cancer Drugs Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4079EUR$4,490USD£3,521GBP

Small Cell Lung Cancer Therapeutics Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4079EUR$4,490USD£3,521GBP

Cytotoxic Drugs & HPAPI Manufacturing Market Industry Trends and Global Forecasts to 2035, by Type of Product, Company Size, Scale of Operation, Type of Molecule, Type of Highly Potent Finished Dosage Form and Key Geographies

 Report
October 2025
442 Pages
Global

From

€4360EUR$4,799USD£3,764GBP

Non-Small Cell Lung Cancer (NSCLC) Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4079EUR$4,490USD£3,521GBP

2,373 Results (Page 12 of 119)
- 1
- 10
- 11
- 12
- 13
- 14

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.